Contact Information

Available for logged-in reporters only

Newswise BETHESDA, Md., February 27, 2014 Six scientific societies will hold their joint scientific sessions and annual meetings, known as Experimental Biology (EB), from April 26-30, 2014, in San Diego. This meeting, EB 2014, brings together the leading researchers from dozens of life-science disciplines. The societies represented at the meeting will be: the American Association of Anatomists (AAA), the American Physiological Society (APS), the American Society for Biochemistry and Molecular Biology (ASBMB), the American Society for Investigative Pathology (ASIP), the American Society for Nutrition (ASN) and the American Society for Pharmacology and Experimental Therapeutics (ASPET).

Below are some programming highlights:

Productive Public-Private Partnerships for Pharmacological Progress (ASPET) This timely symposium will explore new models of productive relationships used by pharmaceutical companies, academia, government and foundations to foster the discovery and development of new therapeutics to address unmet medical needs. Among the topics discussed will be the role of the National Center for Advancing Translational Sciences at the National Institutes of Health in helping to speed delivery of new drugs to patients, how public-private partnerships in the United States and the European Union are carrying out basic science that is relevant to drug discovery and how industry can build successful partnerships with academic institutions while avoiding the usual pitfalls. (Tues., 4/29)

Stem Cells for Heart Repair (ASIP) Heart failure is a leading cause of death, but most of todays therapies only delay the progression of disease. Recent clinical trials and laboratory experiments have conceptually demonstrated how stem cells could be used to repair the heart and improve cardiac function. In this session, leading investigators talk about using cardiac progenitor cells to regenerate contractile heart muscle cells in both developing and aging hearts as well as the potential use of stem cells for forming new vessels in the injured heart. (Sun., 4/27)

Molecular Basis of Addiction: Neurocognitive Deficits and Memory (ASBMB) This symposium will address the emerging idea that addiction is a disease of learning and memory. The general consensus is that the rewarding properties of addictive drugs depend on their ability to ultimately increase dopamine in the brain, but current research does not adequately explain the molecular mechanisms of drug addiction, how repeated dopamine release leads to compulsive use, why the risk of relapse can persist for years and how drug-related cues come to control behavior. This symposium will present new data providing evidence that addiction partly represents a pathological usurpation of processes involved in long-term memory. (Mon., 4/28)

Neurocognition: The Food-Brain Connection (ASN) Does food addiction exist? This double session will take a trans-disciplinary view of the emerging evidence on cognitive neuroscience, nutrition and food/sensory factors involved in understanding the brains role in food consumption. Topics include current perspectives and misunderstandings related to food and the brain as well as methods for studying food reward and control of food intake. (Mon., 4/28)

Signaling by Natural and Engineered Extracellular Matrices (AAA) This mini-meeting will explore how cells and tissues respond to the physical structure and biological properties of natural and engineered extracellular matrices. The presentations will show how interplay and bi-directional interaction between cells and their surrounding extracellular matrix scaffold play a pivotal role in the formation of new organs and tissues. Plenary speakers will discuss matrix-dependent mechanical regulation of organ development; the microenvironment of aging muscle stem cells as a therapeutic target; and how growth factors, the extracellular matrix and microRNAs regulate vessel formation. (Sun., 4/27)

Sex Differences in Physiology and Pathophysiology (APS) Scientists are discovering significant differences between males and females that affect health, illness and how the body responds to therapeutics. This symposium will discuss the latest animal and clinical research on sex differences in both disease and non-disease physiology. Topics include sex differences in chronic kidney disease, sex-specific signaling in heart muscle cells, mechanisms of hypertension in the transition to menopause, and a newly discovered peptide that controls hormonal release from the pituitary gland with differing effects in males and females. (Sun., 4/27)

Excerpt from:
Experimental Biology 2014 Programming at a Glance